IT之家 · ITHome
Musk says Neuralink’s Blindsight engineering is complete, with regulatory approval pending
Musk says Neuralink has completed engineering work on its second brain-computer interface, Blindsight, which still awaits regulatory approval. The device is designed to turn camera images into signals delivered to the visual cortex, aiming to provide visual information to blind people. No human implantation trial results have been publicly disclosed and confirmed.
What to know
- 01
Blindsight received FDA breakthrough device designation in September 2024 but has not been approved for commercial sale.
- 02
Neuralink’s first device, Telepathy, allows people with paralysis to control computers using brain signals and remains in clinical research.
Why it matters
The update concerns a device intended to provide visual information to blind people, but FDA breakthrough designation does not establish its safety or effectiveness.
AI-assisted brief. Read the source for full details. Editorial & sourcing policy
